1Dahlof B,Devereux RB,Kjeldsen SE,et al.Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):A randomized trial against atenolol[J].Lancet,2002,359:995-1003.
2Hansson L,Lithell H,Skoog I,et al.Study on Congnition and Prognosis in the Elderly(SCOPE)[J].Blood Press,1999,8:177-183.
3Guidelines Subcommittee.1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension[J].J Hypertens,1999,17:151-183.
5Lewis EJ,Hunsicker LG,Clarke WR,et al.Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabets[J].N Engl J Med,2001,345:851-860.
6Fauvel JP,velon S,Berra N.Effects of losartan on renal function in patients with essential hypertension[J].J Cardiovase Pharmacol,1996,28:259.
7Andersson OK,Neldam S.The antihypertensive effect and tolerability of candesartan cilexetil,a new generation angiotensin Ⅱ antagonist,in comparison with losartan[J].Blood Press,1998,7:53-59.
8Morrissey JJ,Klahr S.Effect of AT2 receptor blockade on the pathogenesis of renal fibrosis[J].Am J Physiol,1999,276:39-45.
9Siragy HM,Carey RM.The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3',5'-monophosphate and AT1 receptormediated prostaglandin E2 production in conscious rats[J].J Clin Invest,1996,97:1978-1982.
10Conlin PR,Spence,JD,Williams B,et al.Angiotensin Ⅱ antagonists for hypertension:are there differences in efficacy[J].Am J Hypertens,2000,13:418-426.
2Kannel WB. Elevated systolic blood pressure as a cardiovascular risk factor. Am J Cardio1,2000,85:251-255.
3Safar ME. Hypothesis on isolated systolic hypertension in the elderly. J Hum Hypertens, 1999,13:813-815.
4Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens. 1999.17 : 151-183.
5Vardan S, Mookherjee S. Perspectives on isolated systolic hypertension in elderly patients. Arch Farn Med,2000,9:319-323.
6Franklin SS, Jacobs MJ, Wong ND, et al. Predominance of isolated systolic hypertension among mlddle-age and elderly US hypertensives( NHANES Ⅲ）. Hypertension, 2001,37:869-874.
7Caroline TM, Rossum V, Mheen H, et al. Prevalence, treatment,and control of hypertension by sociodemographic factors among the Dutch elderly. Hypertension, 2000,35:814-821.
8Antikainen RL, Jousilahti P, Tuomilehto J, et al. Trends in the prevalence of isolated systolic hypertension in the middle-aged population in 1972-1992. J Hum Hypertens, 1999,13:485-491.
5Ames RP.A comparison of blood lipid and blood pressure responses during the treatment of systemic hypertension with indapamide and with thiazides[J].Am J Cardiol, 1996,77 ( 6 ) : 12b- 16b.
